2m 2m 2m 2m 2m 2m 2m
EVOMMUNE (EVMN)
NYSE
$5.21+$0.04 (+0.70%)
Price as of Oct 22, 2026 7:30 PM EDT- $187.6MMarket Cap
- N/A1-Year Change
- BiotechnologyIndustry
EVOMMUNE (EVMN)
$5.21+$0.04 (+0.70%)
EVMN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.17 | ||
Change | -$0.21 (-3.90%) | ||
Open | $5.41 | ||
High | $5.52 | ||
Low | $5.13 | ||
Previous Close | $5.38 | ||
Volume | 383,385 | ||
30-Day Average Volume | 839,150 | ||
1-Week Change | -10.40% | ||
1-Month Change | -45.29% | ||
1-Year Change | N/A | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 36.3M | ||
Total Assets | $301.9M | ||
Market Cap | $187.6M | ||
Enterprise Value | $127.6M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$32.2M | ||
Free Cash Flow | -$20.5M | ||
EBIT | -$32.2M | ||
EBITDA | -$31.7M | ||
Net Working Capital | $186.8M | ||
EPS | -$0.89 | ||
Enterprise Value/EBITDA | -4 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -6 | ||
PEG | 0 | ||
Price/Free Cash Flow | -9 | ||
Price/Operating Cash Flow | -9 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue